MediXine: Shareholder Chen Jianhuang plans to reduce his holdings by no more than 1.68%.

Medicy announced that as of the date of the announcement, shareholder Chen Jianhuang holds 6.72% of the company's shares, which will be unlocked for trading starting from November 5, 2024. Due to personal financial needs, Chen Jianhuang plans to reduce his holdings by no more than 2.2574 million shares, or no more than 1.68% of the company's total equity, through centralized bidding and block trading from September 7 to December 4, 2026. The implementation of this reduction plan is subject to uncertainty and will not lead to a change in the company's control.